Philips Respironics

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Philips Respironics sits in the top decile of US sponsors by registered trial count (#473 of 15,742 sponsors by registered trial count).

35 total trials none currently recruiting 30 completed top decile by trial count

Philips Respironics: 35 sponsored US clinical trials, none currently recruiting.

Philips Respironics sponsors 35 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 30 completed. The most-studied condition in this pipeline is Obstructive Sleep Apnea, with 2 trials.

Top-decile sponsor footprint

Philips Respironics ranks in the top decile of sponsors by registered trial count (#473 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

30 of 35 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

35 total, page 1 of 1

COMPLETED NA

A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD

NCT03933462

COMPLETED NA

A Study to Determine Preferences Towards Interface Products

NCT03948152

TERMINATED

Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease Patients

NCT03851510

COMPLETED NA

Smart Sleep In-home Validation Extension Study

NCT03665844

COMPLETED

VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)

NCT03590795

COMPLETED NA

Engineering Evaluation of the Helix Ventilator

NCT03613363

COMPLETED NA

Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation

NCT03600194

COMPLETED NA

Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT03349437

COMPLETED NA

In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study

NCT03333876

TERMINATED NA

A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD

NCT02446769

COMPLETED NA

A Study of the Effectiveness and Efficacy of the PowerSleep Device

NCT03162328

COMPLETED NA

Feasibility, Effectiveness and Efficacy of the PowerSleep Device

NCT02797678

TERMINATED NA

The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants

NCT02680639

COMPLETED NA

Servo-Ventilation In-lab PSG Evaluation

NCT02808338

COMPLETED NA

CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence

NCT02195531

COMPLETED NA

User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application

NCT03748264

TERMINATED

Obesity Hypoventilation Syndrome Prevalence Study

NCT01964339

COMPLETED

Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use

NCT01714063

COMPLETED NA

Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator

NCT01679301

COMPLETED NA

30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder

NCT01462305

COMPLETED NA

AVAPS-AE Efficacy Study

NCT01368614

COMPLETED NA

Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients

NCT01450540

COMPLETED NA

Sleep Disordered Breathing and Chronic Pain

NCT01457014

COMPLETED NA

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

NCT01175031

COMPLETED NA

Bipap Automatic Servo Ventilation (autoSV) Advanced in Central Apnea Patients

NCT01199042

COMPLETED NA

High Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)

NCT01214200

COMPLETED NA

Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders

NCT01626989

COMPLETED NA

Evaluation of an Algorithm to Detect Sleep and Wake in Continuous Positive Airway Pressure (CPAP)

NCT01031914

COMPLETED NA

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

NCT00836758

TERMINATED NA

Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device

NCT01241604

COMPLETED NA

Alice PDx User/Validation Extended Trial

NCT00841906

COMPLETED NA

Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device

NCT00720213

COMPLETED NA

Positive Pressure Treatment of Obstructive Sleep Apnea

NCT00636181

COMPLETED NA

Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness

NCT00594022

COMPLETED NA

Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)

NCT02522442

How the Philips Respironics archive is shaped

35 indexed studies, none listed as recruiting (0% open); 30 completed (86%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Obstructive Sleep Apnea (2 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Philips Respironics: archived-pipeline peers nationwide

Peers matched on 35 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Philips Respironics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 010203040 0%5%10%15%20%25% Total trials Recruiting share Philips RespironicsACADIA PharmaceuticalsINSYS TherapeuticsMerz North AmericaPalo Alto Veterans Institute for Research10xBio22nd Century Group23andMe3-C Institute for Social Development
Philips Respironics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Philips Respironics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 35 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Philips Respironics page

35 registered trials is a research-attention snapshot, not an endorsement of Philips Respironics or any single study.

  • None of Philips Respironics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Obstructive Sleep Apnea is the condition Philips Respironics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obstructive Sleep Apnea trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Philips Respironics pipeline card: 35 registered trials from official public datasets.Report a data error.